Steven B Ketchum

CIK 1289884 · EVP, Chief Scientific Officer · last filed 2026-02-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$623.0K

Companies

3

Total Filings

87

Lifetime Open-Market Net

-$24.75M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AMRN EVP, Chief Scientific Officer 40,879 $15.24 $623.0K -$24.80M 69 2026-02-03
Viracta Therapeutics, Inc. (SNSS) Delisted Director 86,378 $18.62 $1.61M $43.5K 17 2020-07-01
Viracta Therapeutics, Inc. (SNSSD) Delisted Sr. Vice President, R & D 72,921 $0 1 2011-03-02

Recent Filings · Page 2 of 9

87 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-12-14 AMRN Sell (S) −34,131 -$27.0K EDGAR
2023-08-02 AMRN Mixed +12,120 -$14.0K EDGAR
2023-07-21 AMRN Grant (A) $0 EDGAR
2023-03-08 AMRN Mixed +8,615 -$15.7K EDGAR
2023-02-23 AMRN Mixed −22,793 -$51.6K EDGAR
2023-01-04 AMRN Mixed +31,406 -$19.8K EDGAR
2022-08-02 AMRN Mixed +15,703 -$10.9K EDGAR
2022-03-02 AMRN Mixed +10,825 -$18.0K EDGAR
2022-02-08 AMRN Grant (A) $0 EDGAR
2022-02-02 AMRN Mixed +7,612 -$17.2K EDGAR
Showing 1120 of 87
Page 2 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.